StonvexLoading…
StonvexStonvexStonvexCore line items from SGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.48B | $4.93B | $4.93B | $4.92B |
Operating Income | $754.90M | $634.20M | $607.20M | $680.60M |
Net Income | $384.10M | $384.30M | $368.10M | $455.70M |
EPS (Diluted) | $1.84 | $2.16 | $2.08 | $2.53 |
Total Assets | $11.60B | $5.98B | $4.55B | $4.36B |
Total Liabilities | $8.48B | $5.41B | $4.22B | $4.37B |
Cash & Equivalents | $134.90M | $1.71B | $74.90M | $69.40M |
Free Cash Flow OCF − CapEx | $633.20M | $569.20M | $384.90M | $72.30M |
Shares Outstanding | 209.20M | 178.20M | 177.30M | 180.30M |